1,2,3,4-TETRAHYDRO-2-NAPHTHYLAMINES

Compounds of the formula I wherein R3 and the NR1R2 group are in a cis-position to each other and wherein Y is OH, R4COO, (R5)2NCOO or R6O either in position 5 or position 7, whereby R4 is an alkyl group having 1-5 carbon atoms or a possibly substituted phenyl group, R5 is an alkyl group having 1-5...

Full description

Saved in:
Bibliographic Details
Main Authors PER ARVID EMIL CARLSSON, ANETTE MARGARETA JOHANSSON, FOLKE LARS-ERIK ARVIDSSON, DOMING SANCHEZ, ULI ALF HACKSELL, JOHN STEPHAN MIKAEL HJORT, PER LENNART LINDBERG, HAKAN VILHELM WIKSTROM, JOHN LARS GUNNAR NILSSON
Format Patent
LanguageEnglish
Published 12.05.1988
Edition4
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of the formula I wherein R3 and the NR1R2 group are in a cis-position to each other and wherein Y is OH, R4COO, (R5)2NCOO or R6O either in position 5 or position 7, whereby R4 is an alkyl group having 1-5 carbon atoms or a possibly substituted phenyl group, R5 is an alkyl group having 1-5 carbon atoms and R6 is an allyl or benzyl group, R1 is hydrogen or an alkyl group having 1-3 carbon atoms, R2 is an alkyl group having 1-6 carbon atoms, a phenylalkyl- or m-hydroxyphenylalkyl group with 2-4 carbon atoms in the alkyl part, or an alkenyl group with 3-6 carbon atoms other than 1-alkenyl, and R3 is an alkyl group having 1-3 carbon atoms, processes and intermediates for their preparation, pharmaceutical preparations and methods of treatment employing such compounds. The compounds are useful for therapeutic purposes, especially for treatment of disorders in the central nervous system.
Bibliography:Application Number: AU19840025879